Study in Patients With Tumours Requiring Arginine to Assess ADI-PEG 20 With Atezolizumab, Pemetrexed and Carboplatin
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Hoffmann-La Roche
Related studies linked through entity extraction aliases.
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
First Line Therapy of Advanced Stage Follicular Lymphoma in Patients < 60 Years Not Eligible fo Standard Immunochemotherapy and in All Patients ≥ 60 Years
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label Crenezumab Study in Participants With Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE3
Participant-Reported Outcomes With the Accu-Chek® Solo Micropump System
- Status
- COMPLETED
- Phase
- NA
A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE1
An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCL
- Status
- COMPLETED
- Phase
- PHASE1
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
- Status
- COMPLETED
- Phase
- PHASE3
Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE3
Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A French Study to Evaluate the Usefulness of an Implantable Continuous Glucose Monitoring (CGM) Sensor to Improve Glycemic Control in Participants With Diabetes Mellitus
- Status
- COMPLETED
- Phase
- NA
ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
- Status
- TERMINATED
- Phase
- PHASE3
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Atezolizumab, Rituximab, Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory DLBCL Not Suitable for High-dose Therapy
- Status
- TERMINATED
- Phase
- PHASE2